Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The SELECT trial, published in The Lancet (October 22, 2025), provides a landmark analysis confirming that the cardioprotective benefits of semaglutide extend beyond weight loss alone. The SELECT Trial: Study Overview The SELECT trial (NCT03574597) enrolled 17,604 participants aged 45 years and above across 41 countries and 804 sites
Vergara participated in a research study that analyzed the brain functions of sleep-deprived participants when shown photos of rich, sweet foods
Full article here: Louder for the peeps in the back.
If your HbA1c levels are not improving as expected, or if you are experiencing symptoms of hyperglycaemia (increased thirst, frequent urination, fatigue), contact your healthcare team
US$ 23.82
US$ 29.97
US$ 23.85
